In the dark quiet of a roadside or a family home in eastern England, a rescue team sometimes meets a body whose heart has stubbornly refused to restart after every familiar measure has been tried. Between mid-2024 and mid-2026, a small group of such patients received one further intervention: a balloon, threaded through the groin and inflated high in the body's great artery, to steer what little circulation remained toward the heart and brain. The findings, offered as preliminary and unconfirmed, suggest that a technique born in trauma care may hold a modest promise for medicine's most despera
Balloon Technique in the Aorta Boosts Blood Flow During Cardiac Arrest in Early Feasibility Study
Adults in cardiac arrest that did not respond to standard advanced life support faced very low survival odds; most did not regain circulation or survive to discharge.
An important first step, but not yet proof that it saves lives
Mark
Why does a bleeding technique show up in cardiac arrest research at all?
Mimi
Because the balloon redirects blood. Block the aorta below the heart and the limited blood CPR produces is pushed toward the heart and brain instead of the lower body.
Mark
And it worked, at least on the numbers?
Mimi
Diastolic pressure went from 26 to 42 mm Hg on average, and the study notes that readings above 35 are linked to a better chance of restarting the heart.
Luke
Careful, though. Those are pressure readings, not survival. What do we actually know about lives?
Mimi
Eight of 33 with confirmed occlusion had sustained circulation, and two went home with good neurological outcomes.
Luke
Two people, with no control group. We can't say what would have happened without the balloon.
Mark
What about the subgroup where four of five regained circulation?
Luke
That's five patients. The researchers themselves call it very small. It's a signal worth chasing, not a result to rely on.
Mimi
Price says as much: an important first step, not proof it saves lives.
Mark
What's still unknown?
Luke
Which patients benefit, how early it must happen, and whether paramedics could do it safely. The study doesn't answer any of those.
Le Pouls
- A physician in a helicopter races against a clock that has already run out, with most patients whose hearts will not restart at the scene never surviving to discharge.
- A balloon designed to stop internal bleeding is pressed into an unfamiliar role, inflated in the upper aorta to push blood toward the brain and heart during failed resuscitation.
- Blood pressure and circulation markers climb sharply in 33 of 36 patients, and no serious adverse effects are recorded, a result that surprises the team itself.
- Eight patients regain sustained circulation and two leave hospital with good brain function, yet the study has no control group and was never designed to prove survival, so the researchers insist this is a first step, not a verdict.
In the dark quiet of a roadside or a family home in eastern England, a rescue team sometimes meets a body whose heart has stubbornly refused to restart after every familiar measure has been tried. Between mid-2024 and mid-2026, a small group of such patients received one further intervention: a balloon, threaded through the groin and inflated high in the body's great artery, to steer what little circulation remained toward the heart and brain. The findings, offered as preliminary and unconfirmed, suggest that a technique born in trauma care may hold a modest promise for medicine's most desperate moments, though whether it truly rescues lives remains a question for the years ahead.
On a roadside in eastern England, or in someone's living room, a helicopter crew arrives to find a patient whose heart has not restarted despite CPR, defibrillation, drugs, and a breathing tube. Between June 2024 and June 2026, for a small group of these patients, the team tried one more thing. A physician from the East Anglian Air Ambulance threaded a slim balloon through an artery in the groin and inflated it inside the aorta, the body's largest artery.
The work, led by James Price, a Cambridge consultant emergency physician, was presented at the American Heart Association's Resuscitation Science Symposium in Chicago. The technique, REBOA, was built for life-threatening internal bleeding, blocking flow to the bleeding below while keeping blood moving to the organs above. Here the balloon sat in the upper aorta, a position that earlier laboratory work suggested could send more blood to the brain and raise the pressure that feeds the heart muscle.
The need is stark. Only about one in ten people survive cardiac arrest outside hospital, and Price notes that options have barely improved in fifty years. Among the 39 adults enrolled, most of whom were men with arrests from medical causes, the balloon blocked the aorta successfully in 33. Diastolic pressure, vital for restarting the heart during CPR, more than doubled at its peak, and circulation markers rose sharply. Price admitted the size of the response, so long after the arrest, surprised him.
The outcomes are encouraging but fragile. Eight patients regained sustained circulation, and two left hospital with good neurological function, a result that is rare after such prolonged arrests. Among patients with witnessed arrests from ventricular fibrillation, treated earlier, four of five regained circulation. The group is tiny, and there was no control group.
Price calls this an important first step, not proof that REBOA saves lives. Larger controlled studies are needed to learn who benefits and when, and the team hopes to test earlier use by specially trained paramedics rather than only physicians.
At a roadside or in someone's home in eastern England, a helicopter team arrives to find a patient whose heart has not restarted despite everything already tried: CPR, defibrillation, drugs, a breathing tube, treatment of any reversible cause. For a small group of such patients between June 2024 and June 2026, the team did one more thing. A physician from the East Anglian Air Ambulance threaded a small balloon through an artery in the groin and inflated it inside the aorta, the body's largest artery.
The results were presented Saturday at the American Heart Association's Resuscitation Science Symposium 2026 in Chicago. They are preliminary, late-breaking and independent. The work was led by James Price, a consultant emergency physician at Cambridge University Hospitals NHS Foundation Trust and consultant lead for research and development with the air ambulance service in Norwich.
The technique is called REBOA, short for resuscitative endovascular balloon occlusion of the aorta. It was developed for life-threatening internal bleeding, where blocking the aorta cuts blood flow to the bleeding area below the balloon while keeping blood moving to vital organs above it. It is mostly used in trauma centers and is not routinely available in emergency medical services in either the United Kingdom or the United States. Here, the balloon was placed in the upper aorta, above the diaphragm, a position called Zone 1. Earlier laboratory work had supported the idea that this could send more blood to the brain and raise the pressure pushing blood into the vessels that feed the heart muscle.
The need is plain. Only about 1 in 10 people survive cardiac arrest outside hospital. CPR restores only a fraction of normal blood flow to vital organs, and death follows when the heart does not restart or the brain goes without oxygenated blood. Price said survival and treatment options have not meaningfully improved in 50 years.
The study enrolled 39 adults, average age 59, of whom 35 were men and 4 women. Their arrests were from medical causes, not injury. The balloon successfully blocked the upper aorta in 33 of 36 patients, and the procedure took about seven minutes. The median time from the arrest to balloon inflation was 51 minutes. No serious adverse effects related to the procedures were reported.
The physiological changes were large. Aortic diastolic pressure, the lower number and one important for restarting the heart during CPR, rose immediately by 59%, from 26 to 42 mm Hg, reaching a maximum of 58 mm Hg, a 118% increase. Average systolic pressure, a key determinant of blood flow to the brain, rose 20%, from 76 to 91 mm Hg. Carbon dioxide in exhaled breath, an indicator of circulation through the lungs, rose 50% on average. Price said this suggests blood was being redirected toward the heart and brain as intended, and that the size of the response, so long after the arrest, surprised him.
Outcomes were not the study's purpose, but they are suggestive. Of 33 patients with confirmed occlusion, eight achieved sustained return of spontaneous circulation, and two were discharged from hospital with good neurological outcomes. In a subgroup with witnessed arrests tied to ventricular fibrillation, treated earlier with occlusion at a median of 44 minutes, four of five regained sustained circulation and two left hospital with good neurological function. The group was very small, though survival with good brain function after such prolonged arrest is normally extremely rare.
The limits are stated plainly. There was no control group, and the study was designed to test feasibility and physiology, not survival. Price called it an important first step but not proof that REBOA saves lives. Larger prospective studies with comparison groups, focused on outcomes that matter to patients, are needed to learn who benefits and when. Researchers also want to test earlier delivery, potentially by specially trained nonphysician responders such as advanced paramedics.
Citations marquantes
This study is an important first step, but it is not yet proof that REBOA saves lives.— James Price, lead author, East Anglian Air Ambulance
Envie de l'histoire complète ?
Lire l'original sur Medical Xpress ↗
Health & Medicine